GlaxoSmithKline Pharmaceuticals (GSK), leading healthcare company, has registered a growth of 6.9 per cent growth in net profit to Rs 141.08 crore during the third quarter ended September 2009 from Rs 131.97 crore in the corresponding period of last year.

However, company’s net sales has grown up by 12 per cent during the quarter, at Rs 511.8 crore against Rs 457 crore in the same period last year.

For the first nine months ended September 2009, the drug maker’s net sales increased by 10.4 per cent to Rs 1,426 crore from Rs 1,292 crore in the similar period of last year.

In addition, company’s net profit grew up by 11 per cent to Rs 408.70 crore, as compared to Rs 368.10 crore.